Han Xu Md Phd Fapcr Sponsor Investigator Irb Chair

We track 1 ClinicalTrials.gov studies led by Han Xu Md Phd Fapcr Sponsor Investigator Irb Chair. The portfolio skews toward Phase 3 (1 trials).

1 clinical trials sponsored by Han Xu Md Phd Fapcr Sponsor Investigator Irb Chair.

Pipeline by Phase

PhaseTrialsDistribution
Phase 3 1
100%

Trial Status Breakdown

Trials by Han Xu Md Phd Fapcr Sponsor Investigator Irb Chair

Explore the Relationship Between Single Nucleotide Polymorphisms and Alectinib Response and Toxicity in Patients With Non-Small Cell Lung Cancer.

NCT05987956 · ACTIVE NOT RECRUITING · Phase 3

Frequently Asked Questions

How many clinical trials does Han Xu Md Phd Fapcr Sponsor Investigator Irb Chair sponsor?

Han Xu Md Phd Fapcr Sponsor Investigator Irb Chair currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 3.

What conditions does Han Xu Md Phd Fapcr Sponsor Investigator Irb Chair research?

Han Xu Md Phd Fapcr Sponsor Investigator Irb Chair conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Han Xu Md Phd Fapcr Sponsor Investigator Irb Chair recruiting for clinical trials?

Check the trial listings below for current recruitment status. Trial recruitment status can change frequently.

Explore More